Patricia is Senior Consultant at Catalyze, focusing on special and high-end projects and applications. She also performs larger assignments for research institutions and companies.
Patricia has a PhD and post-doc experience in Life Sciences, and is consultant at Catalyze since 2011. In 2013, Patricia successfully completed the management and entrepreneurship BioBusiness Masterclass of HollandBio-de Baak. In 2017, Patricia completed the Master course Finance for Growth at the VU University Medical Center. At Catalyze, Patricia has successfully applied for R&D projects valuing over 25 million euros, with awarded projects in national, regional and EU-level programs including Horizon 2020, its SME instruments, EUROSTARS, EuroTransBio, and EFRD. Apart from grant programs, Patricia has experience in performing EU-level project management, composing business cases and business plans, and client-tailored assignments.
Patricia J.W.A.M. Celie obtained her MSc in Medical Biology in 2001 (VU University Amsterdam) and her PhD in 2006 (Molecular Cell Biology & Immunology, VU University Medical Center). In her studies, she focused on adhesion molecules and glycoconjugates at the crossroads of immunity and nephrology. After obtaining her PhD, she expanded her research as a postdoc, specializing in molecular interactions underlying inflammatory responses in primary kidney diseases, transplantation, and renal replacement therapy. In 2009, Patricia turned to the field of oncology, focusing on proteoglycans, cytokines and growth factors in B cell malignancies during her second postdoc at the Dept. Pathology, Academic Medical Center, Amsterdam. During her scientific career, Patricia collaborated with multiple (inter)national research groups, (co)authored scientific articles and grant applications, and coordinated new practical courses for medical students. She acted as representative of PhD-students, and was member of the organizing committee and ambassador for the Postdoc Career Development Initiative (PCDI). At Catalyze, Patricia uses her scientific background and broad interest in Life Sciences to help develop and finance innovative research, bridging the gap between academia and industry.